tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Cellectis SA (CLLS)
NASDAQ:CLLS
CLLS
Cellectis SA
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Cellectis SA (CLLS) Stock News & Sentiment

864 Followers
Cellectis Gains FDA Designations for Leukemia Therapy
PremiumCompany Announcements
Cellectis Gains FDA Designations for Leukemia Therapy
1d ago
6K
CLLS
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
PremiumPress Releases
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
1d ago
CLLS
Monthly information on share capital and company voting rights
PremiumPress Releases
Monthly information on share capital and company voting rights
21d ago
CLLS
Cellectis Shareholders Approve Key Resolutions
PremiumCompany Announcements
Cellectis Shareholders Approve Key Resolutions
28d ago
6K
CLLS
Cellectis Shareholders Support Management’s Vision
PremiumCompany Announcements
Cellectis Shareholders Support Management’s Vision
28d ago
6K
CLLS
Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024
PremiumPress Releases
Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024
28d ago
CLLS
Cellectis Reveals Advances in Gene Editing Efficiency
PremiumCompany Announcements
Cellectis Reveals Advances in Gene Editing Efficiency
1M ago
6K
CLLS
More CLLS News >

CLLS News on the Web

Cellectis Gains FDA Designations for Leukemia Therapy
TipRanks News
Neutral
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia Treatment
Yahoo Finance
Neutral
Regenxbio Surges 18.3%: Is This an Indication of Further Gains?
Yahoo Finance
Neutral
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
Zacks
Neutral
Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis
Yahoo Finance
Neutral
Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)
Zacks
Bullish
Monthly information on share capital and company voting rights
Yahoo Finance
Neutral
Cellectis Shareholders Approve Key Resolutions
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CLLS
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CLLS’s Media Buzz Sentiment?
2 articles about CLLS were published this week. In an average week, 1.75 articles are published.
    What is CLLS’s weekly average amount of articles?
    In an average week, 1.75 articles about CLLS are published.
      What is CLLS’s News Sentiment?
      50% of articles about CLLS were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        IQVIQVIA Holdings
        BSXBoston Scientific
        BHCBausch Health Companies
        HCAHCA Healthcare
        THCTenet Healthcare
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing